Switzerland· 665002
Beriplex P/N 1000
A coagulation factor ix, ii, vii and x in combination product, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Coagulation factor ix, ii, vii and x in combination is registered in 11 of 19 countries.
Countries holding a registration under ATC B02BD01 (coagulation factor ix, ii, vii and x in combination), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 7 of them publish a price we can compare per daily dose
Coagulation factor ix, ii, vii and x in combination · ATC B02BD01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- B02BD01
- ATC class
- Coagulation factor IX, II, VII and X in combination
- Defined daily dose
- 1.6 TSD, E
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- gtin7680006650022Durchstf 1 StkCHF 612.2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for coagulation factor ix, ii, vii and x in combination.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Coagulation factor ix, ii, vii and x in combination · interactions on record
3 records
- 2 severe
- 1 moderate
Most severe, free to view
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- PegvaliaseA16AB19moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B02BD01
Coagulation factor ix, ii, vii and x in combination, as other registers publish it.
- CzechiaBERIPLEXCSL Behring GmbH, Marburg
- CzechiaBERIPLEXCSL Behring GmbH, Marburg
- PolandBeriplex P/N 1000CSL Behring GmbH
- CanadaBERIPLEX P/N 1000CSL BEHRING CANADA INC
- NetherlandsBeriplex P/N 1000 IE, poeder en oplosmiddel voor oplossing voor injectieCSL Behring GmbH
- IrelandBeriplex P/N 1000 IU, powder and solvent for solution for injectionCSL Behring GmbH
- SwitzerlandBeriplex P/N 1000, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungCSL Behring AG
- PolandBeriplex P/N 250CSL Behring GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e84fb9dc-0955-404c-87bd-59f18bbaa45e GET /v1/drugs/e84fb9dc-0955-404c-87bd-59f18bbaa45e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "factor ii coagulationis humanus (prothrombinum) 800-1920 UI + factor vii coagulationis humanus 400-1000 UI + factor ix coagulationis humanus 800-1240 UI + factor x coagulationis humanus 880-2400 UI + proteinum c humanum 600-1800 UI + proteinum s humanum 480-1520 UI",
"valid_from": "2014-09-01",
"limitations": null,
"galenic_form": "Trockensub mit Solv",
"therapeutic_area": null,
"sl_inclusion_date": "2014-09-01",
"self_retention_pct": 10
}See everything about coagulation factor ix, ii, vii and x in combination.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.